Showing 151-160 of 904 results for "".
Should Children and Adolescents Be Screened for Primary Hyperhidrosis?
https://practicaldermatology.com/topics/rare-disease/should-children-and-adolescents-be-screened-for-primary-hyperhidrosis/39946/Should Children and Adolescents Be Screened for Primary Hyperhidrosis?
https://practicaldermatology.com/issues/novemberdecember-2025/should-children-and-adolescents-be-screened-for-primary-hyperhidrosis/48891/Primary hyperhidrosis (PH) is a chronic, often underreported and underdiagnosed condition without a cure. While it frequently runs in families, the exact etiology is unknown.Update on Atopic Dermatitis 2018
https://practicaldermatology.com/topics/general-topics/update-on-atopic-dermatitis-2018/20354/A look at the pathophysiology of AD, including structural and immunologic contributors, as well as new therapeutic developments with an eye toward breakthroughs on the horizon.Practical Considerations for Treating Psoriasis: Focus on Secukinumab
https://practicaldermatology.com/topics/psoriasis/practical-considerations-for-treating-psoriasis-focus-on-secukinumab/20841/Systemic Inflammation in Psoriasis: A Guide for Dermatology Care Providers
https://practicaldermatology.com/topics/psoriasis/systemic-inflammation-in-psoriasis-a-guide-for-dermatology-care-providers/20439/Practical guidance for dermatology care providers on the importance of screening patients with psoriasis for associated comorbidities.Keratosis Pilaris: A Rough and Bumpy Review
https://practicaldermatology.com/columns/clinical-focus-1/keratosis-pilaris-a-rough-and-bumpy-review/23618/There are promising interventions for this challenging presentation.Advanced Management Solutions for High-Grade Cutaneous Toxicities to Cancer Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advanced-management-solutions-for-high-grade-cutaneous-toxicities-to-cancer-therapy/57176/The emergence of immune checkpoint inhibitors (ICIs) has fundamentally altered the prognosis for patients with advanced skin malignancies, yet the high incidence of cutaneous immune-related adverse events (irAEs) remains a significant barrier to treatment continuity. Here, we review the clinical manWhen to Consider Therapeutic Switching in Plaque Psoriasis: Best Practices for Nurse Practitioners, Physician Assistants, and Physicians
https://practicaldermatology.com/topics/psoriasis/when-to-consider-therapeutic-switching-in-plaque-psoriasis-best-practices-for-nurse-practitioners-physician-assistants-and-physicians/21054/What to know about patient experiences and the proper approaches to modifying treatment regimens.Apocrine Hidrocystoma of the Axilla
https://practicaldermatology.com/issues/october-2025/apocrine-hidrocystoma-of-the-axilla-an-illustrative-case-and-literature-review/39757/An Illustrative Case and Literature ReviewAntioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.